Oncology Research Program
The Helen G. Nassif Community Cancer Center is a community based comprehensive cancer center offering programs and services that span from prevention and screening to diagnosis, treatment and research. Providing care that is respectful of and responsive to individual patient preferences, needs and values guides all of our clinical decisions.
In collaboration with Physicians’ Clinic of Iowa Hematology/Oncology and the St. Luke’s Nassif Radiation Center, we conduct meaningful and beneficial clinical trials (research studies) for many different types of cancer. We participate in research programs with several respected national organizations funded by the National Cancer Institute. In addition, we partner with oncology organizations across the country to give our patients access to additional clinical trials.
What is a Clinical Trial?
Clinical trials are research studies that involve people. Through clinical trials, doctors find new ways to improve treatments and the quality of life for people with disease.
Researchers design cancer clinical trials to test new ways to:
- Treat your cancer
- Find and diagnose cancer
- Prevent cancer
- Manage symptoms of cancer and side effects from treatment
The Five Common Types of Clinical Trials
Who Can Participate in a Clinical Trial?
Based on questions the research is trying to answer, each clinical trial will state the criteria for who can and cannot participate. The criteria helps ensure the group selected is as similar as possible, that way doctors can be sure the results are due to the treatment and not other factors.
A searchable database for cancer clinical trials is available through the American Cancer Society and clinicaltrials.gov. You can search for available clinical trials in your area based on cancer type, treatment history and current condition.
Whether you are newly diagnosed or a cancer survivor we are here to help and support you in any way we can. If you are interested in learning more about clinical research trials we have open at our site please call us at (319) 368-5514.
The DCISionRT Test
DCISionRT uses tissue from a biopsy or surgery of the breast to create a cancer risk profile for each individual patient based on the biology of their tumor. DCISionRT is intended to be used along with your provider’s evidence-based workup to determine if you would benefit from radiation therapy as part of treatment that is personalized to you.
Your unique profile will be combined with several risk factors using the DCISionRT algorithms to determine your individual risk profile. This will help you and your physician understand your risk of recurrence over the next ten years and decide if radiation therapy as part of your treatment plan will decrease this risk.
Patients will need a consult at the St. Luke’s Nassif Radiation Center prior to testing. If you are interested in learning more about DCISionRT or other clinical research trials we have open at our site please call us at (319) 368-5514.